The integration of telehealth into the management of chronic conditions like diabetes, obesity, and weight management represents a meaningful advancement in modern healthcare
Individuals are not eligible for both
This distinction matters because medication selection should reflect individual biomarker profiles and genetic predispositions, not a standardized approach
Curr Med Chem 19(23):4000
Chen said, pointing to preclinical studies showing reduced alcohol intake in mice and an exploratory analysis of a randomized trial suggesting that exenatide decreased heavy drinking days in patients with alcohol use disorder (AUD) and obesity
Several active treatments, particularly tirzepatide 5 mg, 10 mg, and 15 mg, were directly compared within multi-arm trials